Endeavour Silver
EXK
8.32
-0.35
-4.04%
Endeavour Silver
US · EXK
#2622 by market cap
Listed 1970
8.32
-0.35
-4.04%
Live - 5344 symbols - heartbeat 423s ago
· 2026-10-08 08:09
Pre-market
8.29
-0.36%
After-hours
8.39
+0.84%
Overnight
8.29
-0.36%
- Market cap
- 2.46B
- P/E (TTM)i
- 41.60
- P/Bi
- 3.46
- EPSi
- -0.42
- Div yieldi
- 0.00%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on EXK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.32, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +114.84% YoY
Margins
- Gross margin
- 17.63%
- Operating margin
- 8.24%
- Net margin
- -25.48%
Key ratios & quality
- Enterprise valuei
- 2.49B
- Altman Z-Scorei
- 2.32
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 150.51M | 117.42M | 138.46M | 165.32M | 210.16M | 205.46M | 217.60M | 467.50M |
| Gross profit | 3.25M | -17.68M | 27.13M | 36.20M | 51.31M | 36.24M | 41.60M | 82.40M |
| Selling & admin expenses | 8.37M | 9.66M | 12.51M | 9.90M | 10.40M | 11.99M | 13.80M | 19.30M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -17.65M | -39.55M | -743.00K | 6.76M | 23.67M | 8.56M | 7.70M | 38.50M |
| Pretax profit | -17.71M | -44.00M | -1.05M | 29.69M | 24.95M | 18.25M | -22.00M | -104.90M |
| Tax | -5.27M | 4.06M | -2.21M | 15.73M | 18.75M | 12.13M | 9.50M | 14.20M |
| Net profit | -12.44M | -48.07M | 1.16M | 13.96M | 6.20M | 6.12M | -31.50M | -119.10M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.10 | -0.36 | 0.01 | 0.08 | 0.03 | 0.03 | -0.13 | -0.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 63.50M | 88.60M | 142.83M | 172.57M | 209.70M | 212.10M |
| Gross profit | 12.80M | 7.60M | 15.51M | 46.51M | 93.30M | 73.90M |
| Selling & admin expenses | 4.10M | 7.50M | 6.44M | 4.79M | 4.60M | 2.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.20M | -4.80M | 1.81M | 33.84M | 83.70M | 64.70M |
| Pretax profit | -27.80M | -14.60M | -37.46M | -25.04M | 85.90M | 79.50M |
| Tax | 5.10M | 5.90M | 4.50M | -1.26M | 21.00M | 13.00M |
| Net profit | -32.90M | -20.50M | -41.96M | -23.78M | 64.90M | 66.50M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.13 | -0.07 | -0.14 | -0.08 | 0.23 | 0.21 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 78.01M | 63.28M | 104.97M | 161.76M | 146.33M | 100.77M | 157.60M | 423.20M |
| Cash & ST investments | 33.46M | 23.44M | 65.85M | 114.50M | 92.04M | 40.42M | 107.50M | 216.40M |
| Inventory | 14.89M | 13.59M | 16.64M | 27.49M | 19.18M | 27.26M | 36.00M | 62.30M |
| Total assets | 177.05M | 163.71M | 210.59M | 294.02M | 399.44M | 474.81M | 719.20M | 1.24B |
| Total current liabilities | 23.52M | 24.84M | 34.55M | 40.55M | 52.75M | 58.24M | 78.90M | 276.80M |
| Short-term debt | -- | 3.12M | 3.75M | 4.34M | 6.30M | 3.86M | 5.20M | 8.80M |
| Long-term debt | -- | 5.92M | 6.09M | 6.37M | 8.47M | 4.66M | 115.00M | 235.00M |
| Total liabilities | 32,267,000.00 | 40,920,000.00 | 51,521,000.00 | 56,617,000.00 | 83,543,000.00 | 88,466,000.00 | 234,800,000.00 | 656,600,000.00 |
| Total equity | 144.78M | 122.79M | 159.07M | 237.41M | 315.89M | 386.34M | 484.40M | 579.10M |
| Retained earnings | -324.01M | -370.86M | -368.30M | -354.33M | -348.09M | -340.91M | -372.20M | -491.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 120.63M | 197.88M | 207.93M | 423.20M | 422.90M | 435.40M |
| Cash & ST investments | 65.91M | 52.80M | 58.12M | 216.40M | 240.90M | 243.40M |
| Inventory | 39.06M | 60.02M | 58.35M | 62.30M | 75.60M | 71.30M |
| Total assets | 727.99M | 995.89M | 1.02B | 1.24B | 1.25B | 1.27B |
| Total current liabilities | 105.83M | 213.23M | 263.99M | 276.80M | 249.50M | 221.00M |
| Short-term debt | 10.14M | 39.51M | 44.30M | 8.80M | 8.20M | 2.70M |
| Long-term debt | 112.30M | 122.10M | 114.76M | 235.00M | 239.50M | 244.10M |
| Total liabilities | 275,942,000.00 | 466,807,000.00 | 508,222,000.00 | 656,600,000.00 | 609,000,000.00 | 559,800,000.00 |
| Total equity | 452.05M | 529.09M | 508.80M | 579.10M | 644.70M | 712.40M |
| Retained earnings | -405.06M | -425.52M | -467.47M | -491.30M | -426.40M | -359.90M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 26.65M | -9.58M | 38.96M | 23.46M | 54.99M | 11.77M | 19.10M | 67.40M |
| Depreciation & amortization | 38.78M | 32.05M | 28.86M | 24.53M | 26.09M | 28.79M | 31.10M | 73.80M |
| Free cash flow | -13.75M | -31.38M | 13.43M | -30.63M | -54.72M | -106.02M | -176.30M | -101.80M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | 8.27M | 23.56M | 26.37M | 57.64M | 46.00M | 60.67M | 122.40M | 70.50M |
| Ending cash balance | 33.38M | 23.37M | 61.08M | 103.30M | 83.39M | 35.29M | 106.40M | 223.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 3.40M | 21.50M | 27.05M | 15.42M | 20.70M | 39.80M |
| Depreciation & amortization | 9.50M | 15.20M | 24.09M | 24.98M | 21.30M | 26.10M |
| Free cash flow | -38.20M | -32.70M | -7.60M | -23.39M | -17.20M | 10.70M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | -- | 46.60M | 14.78M | 9.16M | -- | 0 |
| Ending cash balance | 64.70M | 52.20M | 57.03M | 223.70M | 231.80M | 236.60M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -8.54 | -35.93 | 0.82 | 7.04 | 2.24 | 1.74 | -7.23 | -22.40 |
| ROA %i | -7.00 | -28.21 | 0.62 | 5.53 | 1.79 | 1.40 | -5.27 | -12.18 |
| ROIC %i | -8.54 | -33.20 | 1.21 | 6.92 | 2.34 | 1.82 | -6.14 | -15.94 |
| 5-year avg ROE %i | -30.79 | -31.33 | -6.50 | -5.94 | -6.87 | -4.82 | 0.92 | -3.72 |
| EBIT margin %i | -11.73 | -35.83 | -0.10 | 18.40 | 12.25 | 9.28 | -9.69 | -21.09 |
| FCF / sales %i | -- | -- | 9.70 | -- | -- | -- | -- | -- |
| Current ratioi | 3.32 | 2.55 | 3.04 | 3.99 | 2.77 | 1.73 | 2.00 | 1.53 |
| Quick ratioi | 2.57 | 1.87 | 2.49 | 3.18 | 2.09 | 1.13 | 1.49 | 1.11 |
| Debt / assetsi | 0.00 | 6.18 | 5.11 | 3.91 | 3.90 | 1.79 | 16.71 | 19.73 |
| LT debt / equityi | -- | 5.69 | 4.41 | 3.02 | 2.94 | 1.21 | 23.74 | 40.58 |
| Interest coveragei | -- | -110.69 | -0.15 | 42.06 | 32.58 | 23.21 | -23.73 | -15.65 |
| Revenue CAGR (3Y) %i | -6.40 | -9.18 | -2.74 | 3.18 | 21.41 | 14.06 | 9.59 | 30.54 |
| Net income CAGR (3Y) %i | -- | -- | -50.72 | -- | -- | 74.16 | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -14.41 | -14.53 | -20.46 | -22.40 | -3.88 | 10.58 |
| ROA %i | -10.21 | -8.82 | -11.58 | -12.18 | -2.15 | 5.79 |
| ROIC %i | -12.38 | -11.51 | -15.83 | -15.94 | -1.95 | 9.22 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -24.41 | -22.40 | -23.48 | -21.09 | 3.34 | 16.16 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.14 | 0.93 | 0.79 | 1.53 | 1.69 | 1.97 |
| Quick ratioi | 0.72 | 0.59 | 0.52 | 1.11 | 1.36 | 1.60 |
| Debt / assetsi | 16.82 | 16.23 | 15.64 | 19.73 | 19.76 | 19.40 |
| LT debt / equityi | 24.84 | 23.08 | 22.56 | 40.58 | 37.15 | 34.26 |
| Interest coveragei | -53.50 | -29.98 | -33.85 | -15.65 | 1.75 | 7.35 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Guanacevi is the largest reported line at 35.83% of revenue, across 3 reported segments.
- No single line clears half of revenue; Terronera is next at 32.91%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Guanacevi35.83%
Terronera32.91%
Kolpa31.26%
Quote time 2026-10-08 08:09:21 · For reference only, not investment advice and not tailored to your situation.